started on semaglutide (WEGOVY) shouldbe titrated according to the recommended schedule available in the prescribing information. Patient education will need to be provided. Table 1. Conversion from iraglutide (SAXENDA) to l semaglutide (WEGOVY) for weight management . If current dose of liraglutide (SAXENDA) is:
Nov 30, 2022 · Beth Israel Lahey Health GLP-1RA Conversion Guide 11/2022 The purpose of this guide is to assist with the conversion of GLP1-RA’s due to current product shortages. Assessment of equivalent ... Summary of Clinical Evidence and Comparison Chart References: • Almandoz J, Lingvay I, Morales J et al. Switching between Glucagon-Like Peptide-1 ...
WEGOVY into a muscle (intramuscularly) or vein (intravenously). • Change (rotate) your injection site with each injection. Do not. use the same site for each injection. • Use WEGOVY 1 time each week, on the same day each week, at any time of the day. • Start WEGOVY with 0.25 mg per week in your first month.
Saxenda to Wegovy Dose Conversion: A Comprehensive Guide
When transitioning from Saxenda to Wegovy, it is essential to follow the recommended dose conversion guidelines to ensure the appropriate dosage of Wegovy for your weight loss treatment. Here are the general guidelines: If you are currently using Saxenda at a dose of 0.6 mg, the equivalent dose of Wegovy would be 2.4 mg.
What to know about prescribing Wegovy™ How to prescribe once-weekly Wegovy™ Wegovy™ comes in 5 packs (one for each strength). Each pack contains 4 Wegovy™ pens (one pen for each week). Prescribing Strength NDC Days Supply Dispense Quantity Recommended SIG 0.25 mg/0.5 mL 0.5 mg/0.5 mL 1 mg/0.5 mL 1.7 mg/ 0.75 mL 0169-4525-14 0169-4505-14 ...
Select patients for WEGOVY treatment as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management based on their BMI. BMI is calculated by dividing weight (in kilograms) by height (in meters) squared. A chart for determining BMI based on height and weight is provided in Table 1.
Dosing with Wegovy™ • Start Wegovy™ with a dose of 0.25 mg (the dose you received in this kit) once per week in your first month • In your second month, increase your weekly dose to 0.5 mg • In your third month, increase your weekly dose to 1 mg • In your fourth month, increase your weekly dose to 1.7 mg • n I your fifth month, you’ll increase your weekly dose to 2.4 mg.
- [PDF]
Wegovy PI
• ®Administer WEGOVY in combination with a reduced-calorie diet and increased physical activity. • ®Administer WEGOVY once weekly, on the same day each week, at any time of day, with or without meals. • ®Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm. The time of day and the injection site can be
VA Formulary Advisor - Veterans Affairs
Clinical Recommendations: Semaglutide (WEGOVY) Subcutaneous Injection Conversion Guidance for Weight Management (ID# 410)
- [PDF]
Wegovy - MPR
Placebo Wegovy Placebo Wegovy Placebo Wegovy Body Weight at baseline (kg) 105.2 105.4 100.5 99.9 103.7 106.9 % of patients losing ≥5% body weight 31.1 83.5 30.2 67.4 47.8 84.8 % change from baseline